Maria V. Sacchi
Alessandria, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.
Journal: The Lancet. Haematology
Published: April 28, 2025
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Journal: EClinicalMedicine
Published: November 22, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Journal: Leukemia & lymphoma
Published: November 15, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 19, 2023
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
Journal: Cancers
Published: October 11, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
Journal: Hematological oncology
Published: May 23, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey.
Journal: Blood advances
Published: February 17, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Journal: Haematologica
Published: February 11, 2022
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Journal: Journal of hematology & oncology
Published: July 09, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026